Coagulation panel: D-dimer elevated
Feb 23, 2023
Source: Cainiu Health
Dr. Zhang Heyang
Introduction
Elevated D-dimer levels in the five-item coagulation panel may be caused by conditions such as cerebral infarction, myocardial infarction, or pulmonary embolism. Appropriate treatment plans should be selected based on the specific underlying cause. In addition, elevated D-dimer levels may indicate that the patient has an underlying autoimmune disease, which often leads to secondary dysfunction of fibrinolytic activity and results in persistent hyperactivity.
Elevated D-dimer levels in a coagulation panel may be caused by conditions such as cerebral infarction, myocardial infarction, or pulmonary embolism. Appropriate treatment plans should be selected based on the specific underlying cause.
1. Cerebral Infarction
Cerebral infarction primarily results from atherosclerosis in the neck or intracranial blood vessels. As the disease progresses, atherosclerotic plaques form, leading to thrombus development, interruption of blood flow, and ultimately cerebral infarction. Coagulation tests typically reveal elevated D-dimer levels in the coagulation panel. Under medical guidance, thrombolytic medications can be used for treatment. In some cases, endovascular stenting may be necessary.
2. Myocardial Infarction
Elevated D-dimer levels may indicate myocardial infarction. Long-term smoking and consumption of fatty foods can lead to coronary artery atherosclerosis, blocking blood supply to the heart, commonly causing symptoms such as chest tightness and palpitations. Treatment under medical supervision may include medications like aspirin tablets and nitroglycerin.
3. Pulmonary Embolism
Pulmonary embolism occurs when vascular wall damage leads to abnormal coagulation function. Hospital testing often reveals elevated D-dimer levels in the coagulation panel. Anticoagulant medications, such as unfractionated heparin or low-molecular-weight heparin, can be administered under medical guidance.
In addition, elevated D-dimer levels may also occur in patients with underlying autoimmune diseases, which often trigger secondary abnormalities in fibrinolytic function, resulting in persistent hyperactivity.
